Sentry Data Systems, Inc. is proud to share a recent article in Health Systems Management authored by one of our top thought leaders, Tim Lantz, SVP of Analytics.
Receive a free 340B essentials kit just for stopping by our booth at the 340B Coalition Summer Conference ― and get entered into a drawing to win a $150 Amex gift card! We’ll also donate $5 on your behalf to support the 340B Coalition’s charity fundraiser.
Today, Sentry Data Systems, Inc. announced its acquisition of Nashville-based Agilum Healthcare Intelligence.
Sentry Data Systems, Inc., the 2014 KLAS Category Leader for 340B Management Solutions and provider of SaaS-based technology solutions that help healthcare providers manage costs, compliance and outcomes, announced today the addition of Dr. Lisa M. Scholz to the company’s executive leadership team as SVP, Market Strategy.
A federal district court ruling last week struck down interpretive guidance issued last year by the Health Resources and Services Administration (HRSA) relating to 340B pricing on orphan drugs for certain 340B covered entities.
A congressional investigation, in the works for more than a year, may produce refunds for 340B covered entities as a result of overcharges from drug manufacturers participating in the 340B program.
The Health Resources and Services Administration (HRSA) released a preview copy of their long-awaited omnibus guidance today, following the completion of a required review by the Office of Management and Budget.